1.05
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché CTSO Giù?
Forum
Previsione
Frazionamento azionario
Cytosorbents Corp Borsa (CTSO) Ultime notizie
What analysts say about Cytosorbents Corporation stockUnmatched market performance - jammulinksnews.com
What drives Cytosorbents Corporation stock priceStrongest growth potential - jammulinksnews.com
Why Cytosorbents Corporation stock attracts strong analyst attentionBreakout Momentum Stocks - Newser
Cytosorbents (NASDAQ:CTSO) Given “Buy” Rating at D. Boral Capital - Defense World
CytoSorbents (CTSO) Stock Rating and Price Target Maintained by - GuruFocus
Is Cytosorbents Corporation a good long term investmentExtraordinary profit generation - jammulinksnews.com
What institutions are buying Cytosorbents Corporation stock nowLong Term Low Risk Growth - Newser
What makes Cytosorbents Corporation stock price move sharplyRisk Controlled Trading Ideas - Newser
Cytosorbents stock plunges after regulatory setbacks for key device - Investing.com
CytoSorbents provides FDA, Health Canada regulatory update for DrugSorb-ATR - TipRanks
Cytosorbents Provides U.S. FDA And Health Canada Regulatory Update For Drugsorb-Atr - TradingView
CytoSorbents receives FDA appeal hearing date for DrugSorb-ATR device - Investing.com
CytoSorbents Provides U.S. FDA and Health Canada Regulatory Update for DrugSorb-ATR - PR Newswire
Cytosorbents Corporation(NasdaqCM: CTSO) added to Russell Microcap Index - MarketScreener
CytoSorbents files appeal with FDA over denied device application - Investing.com
CytoSorbents Q1 2025 slides: Revenue dips 3% as company targets breakeven by year-end - Investing.com
Millennium Management LLC Buys Shares of 33,280 Cytosorbents Co. (NASDAQ:CTSO) - Defense World
Cytosorbents announces voting results from annual meeting By Investing.com - Investing.com Canada
Cytosorbents announces voting results from annual meeting - Investing.com
CytoSorbents Warrants Expire Worthless as Stock Price Fails Threshold - Investing.com
Cytosorbents Co. (NASDAQ:CTSO) Shares Purchased by Northern Trust Corp - Defense World
Critical Care Leader CytoSorbents Reveals Growth Strategy at Jefferies Healthcare Conference - Stock Titan
Cytosorbents Therapy Significantly Reduces Bleeding in Urgent CABG Patients on Ticagrelor in New Data Presented At EuroPCR 2025 - marketscreener.com
CytoSorbents device cuts bleeding in CABG patients - Investing.com
New Clinical Data: How CytoSorbents' Breakthrough Device Slashes Severe Bleeding Risk in Urgent Heart Surgery - Stock Titan
Cytosorbents (NASDAQ:CTSO) Coverage Initiated by Analysts at StockNews.com - Defense World
Cytosorbents FY2025 EPS Forecast Lifted by HC Wainwright - Defense World
D. Boral Capital Reiterates “Buy” Rating for Cytosorbents (NASDAQ:CTSO) - Defense World
Cytosorbents (NASDAQ:CTSO) Earns Neutral Rating from HC Wainwright - Defense World
Cytosorbents Corporation (NASDAQ:CTSO) Q1 2025 Earnings Call Transcript - Insider Monkey
Cytosorbents Corp’s Earnings Call: A Balanced Outlook - TipRanks
CytoSorbents (CTSO) Receives Neutral Rating from HC Wainwright & Co. | CTSO Stock News - GuruFocus
CytoSorbents (CTSO) Maintains Buy Rating with $10 Price Target | - GuruFocus
CytoSorbents (CTSO) Maintains Buy Rating with $10 Price Target | CTSO Stock News - GuruFocus
CytoSorbents: Q1 Earnings Snapshot - CT Insider
CytoSorbents Corp (CTSO) Q1 2025 Earnings Call Highlights: Navigating Challenges and ... - Yahoo Finance
CytoSorbents Corp (CTSO) Q1 2025 Earnings Call Highlights: Navigating Challenges and Strengthening Financials - GuruFocus
StockNews.com Initiates Coverage on Cytosorbents (NASDAQ:CTSO) - Defense World
CytoSorbents (CTSO) Targets Growth Amid Regulatory Challenges - GuruFocus
Earnings call transcript: CytoSorbents Q1 2025 misses earnings, stock dips - Investing.com
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):